Lyra Therapeutics Inc (LYRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 458 | 410 | 11 | 359 | 525 |
| Gross Profit | 458 | 410 | 11 | 359 | 525 |
| Operating Expenses | 16,961 | 17,723 | 15,166 | 15,185 | 14,925 |
| Operating Income | -16,503 | -17,313 | -15,155 | -14,826 | -14,400 |
| Other Income | 897 | 1,072 | 933 | 60 | 34 |
| Pre-tax Income | -15,606 | -16,241 | -14,222 | -14,766 | -14,366 |
| Income Tax | 12 | 14 | N/A | N/A | N/A |
| Net Income Continuous | -15,618 | -16,255 | -14,235 | -14,766 | -14,366 |
| Net Income | $-15,618 | $-16,255 | $-14,235 | $-14,766 | $-14,366 |
| EPS Basic Total Ops | -18.00 | -22.00 | -4.50 | -20.00 | -21.00 |
| EPS Basic Continuous Ops | -17.88 | -22.07 | -4.42 | -20.05 | -21.16 |
| EPS Diluted Total Ops | -18.00 | -22.00 | -4.50 | -20.00 | -21.00 |
| EPS Diluted Continuous Ops | -17.88 | -22.07 | -4.42 | -20.05 | -21.16 |
| EBITDA(a) | $-17,152 | $-17,755 | $-15,425 | $-14,547 | $-14,114 |